和多基基物质通过升高上皮质通道诱导盐敏感高血压 - 这是支持因果关系的第一个实验证据
bioRxiv : the preprint server for biology
|September 26, 2025
概括
暴露于和多基物质 (PFAS) 会通过影响上皮质通道,在雄性小鼠中引起高血压和损伤. 这项研究提供了因果关系证据,将PFAS与对盐敏感的高血压和损伤联系起来.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 脏生理学 脏生理学
背景情况:
- 和多基基物质 (PFAS) 是广泛存在的合成化学物质,在人类研究中与高血压和功能障碍有关.
- PFAS引起的健康影响的因果关系和机制尚不清楚.
研究的目的:
- 研究四种常见 PFAS (PFOA,PFOS,PFHxS,PFNA) 混合物对小鼠血压,盐敏感性和损伤的因果作用.
- 阐明涉及到PFAS毒性的基础上皮质机制.
主要方法:
- 129S6小鼠在3周内暴露在4个PFAS的低剂量或高剂量混合物中.
- 评估了血压,盐敏感性和组织学.
- 单细胞RNA测序和西式涂抹被用于分析脏组织.
主要成果:
- 在雄性小鼠中,暴露于PFAS诱导了剂量依赖的高血压和盐敏感性,伴随着球病变和间歇性纤维化.
- 的转录分析揭示了近道管,厚的上升四肢和收集管的变化,影响胆固醇合成,线粒体呼吸和传送活性.
- PFAS增加了脏αENaC的表达,并减少了Nedd4-2酸化,表明ENaC降解受损.
结论:
- 暴露于PFAS会导致高血压,盐敏感性和雄性小鼠损伤.
- 上皮质机制,特别是涉及上皮质通道 (ENaC),与PFAS毒性有关.
- 这些发现支持并扩大了关于PFAS对健康有害影响的人类流行病学观察.
更多相关视频
08:08Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
11.8K
07:51Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
29.4K
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
Hypertension II: Pathophysiology
795
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
Hypertension and Regulation of Blood Pressure
3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Antihypertensive Drugs: Action of Diuretics
2.2K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.2K
Hormonal Regulation of Blood Pressure
5.9K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.9K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.5K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.5K
